In our previous study, we found that β-cryptoxanthin prevented the development of NASH by attenuating fat accumulation, increases in KC numbers, activation of stellate cells, and fibrosis in mouse models of lipotoxicity-induced NASH [101,111]. The gene discussed is CALCA; the disease is metabolic dysfunction-associated steatohepatitis.